Page last updated: 2024-10-29

indapamide and Syndrome

indapamide has been researched along with Syndrome in 1 studies

Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.

Syndrome: A characteristic symptom complex.

Research Excerpts

ExcerptRelevanceReference
" We report a 50-year-old hypertensive woman on Indapamide presenting with malaise, dizziness and serum sodium less than 100mmol/l who developed osmotic demyelination syndrome after correction of the hyponatremia."3.91Plasmapheresis to treat Osmotic Demyelination Syndrome from overly rapid plasma sodium correction. ( Chia, YK; Dhayalen, K; Fung, YK; Gayathri, DK, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gayathri, DK1
Dhayalen, K1
Chia, YK1
Fung, YK1

Other Studies

1 other study available for indapamide and Syndrome

ArticleYear
Plasmapheresis to treat Osmotic Demyelination Syndrome from overly rapid plasma sodium correction.
    The Medical journal of Malaysia, 2019, Volume: 74, Issue:4

    Topics: Antihypertensive Agents; Biomarkers; Demyelinating Diseases; Female; Humans; Hyponatremia; Indapamid

2019